Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate‐to‐severe atopic dermatitis: A network meta‐analysis
N
Shared by NobleBlocks on Jul 27, 2022 • 12:00 AM UTC
Authors:
Huiying Wan
,
Haiping Jia
,
Tian Xia
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate‐to‐severe atopic dermatitis: A network meta‐analysis | NobleBlocks
